Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference

PR Newswire May 28, 2021

SOFIE to Commercially Supply FDA-Approved PYLARIFY® (piflufolastat F 18) Injection

PR Newswire May 28, 2021

Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome

PR Newswire May 27, 2021

AffaMed Therapeutics Announces Approval for the Phase IIb Clinical Study of AM006 in China for the Treatment of Parkinson's Disease

PR Newswire May 27, 2021

Bio-Rad to Participate at Jefferies Virtual Healthcare Conference

Business Wire May 20, 2021

Bio-Rad Reports First-Quarter 2021 Financial Results

Business Wire April 29, 2021

Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021

Business Wire April 15, 2021

Bio-Rad to Participate in Barclays Global Healthcare Conference 2021

Business Wire March 5, 2021

Bio-Rad to Participate in Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference

Business Wire February 22, 2021

Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results

Business Wire February 11, 2021

Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021

Business Wire January 25, 2021

Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11

Business Wire January 8, 2021

Bio-Rad Provides Outlook Through 2023

Business Wire December 10, 2020

Bio-Rad Reports Third-Quarter 2020 Financial Results

Business Wire October 29, 2020

Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020

Business Wire October 19, 2020

The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court's Award of Damages

Business Wire August 4, 2020

Bio-Rad Reports Second-Quarter 2020 Financial Results

Business Wire July 30, 2020

Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020

Business Wire July 15, 2020

S&P Dow Jones Indices Announces Tyler Technologies, Bio-Rad Laboratories and Teledyne Technologies Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PR Newswire June 12, 2020

Bio-Rad Reports First-Quarter 2020 Financial Results

Business Wire May 6, 2020